Richmond, VA, United States of America

Alberto Vera



Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alberto Vera

Introduction

Alberto Vera is a notable inventor based in Richmond, VA, who has made significant strides in the field of cancer research. His work focuses on developing novel therapeutic agents that target cancer stem cells, which are often resistant to conventional treatments. With a strong academic background and a commitment to advancing medical science, Vera has contributed to the understanding and treatment of cancer.

Latest Patents

Alberto Vera holds a patent for "Lipidic analogs of anti-cancer stem cell agent." This innovative patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These agents display promising in vivo anti-cancer activity through selective inhibition of cancer stem cells, while sparing adult or hematopoietic stem cells. The compounds exhibit high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window. This patent highlights Vera's dedication to finding effective solutions in the fight against cancer.

Career Highlights

Vera is affiliated with Virginia Commonwealth University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on cancer treatment and has positioned him as a key figure in the ongoing battle against this disease. With 1 patent to his name, Vera continues to push the boundaries of scientific research.

Collaborations

Throughout his career, Alberto Vera has worked alongside esteemed colleagues such as Umesh R Desai and Balaji Nagarajan. These collaborations have enriched his research and contributed to the development of innovative cancer therapies.

Conclusion

Alberto Vera's contributions to cancer research through his innovative patent and collaborations with other experts underscore his commitment to improving patient outcomes. His work exemplifies the importance of targeted therapies in the fight against cancer, and his ongoing research promises to yield further advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…